{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:44:27Z","timestamp":1791434667084,"version":"4.3.3"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00801-2","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T20:58:30Z","timestamp":1737061110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates"],"prefix":"10.1007","volume":"26","author":[{"given":"Omkar Kumar","family":"Kunwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-6632","authenticated-orcid":false,"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"8","key":"801_CR1","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3390\/ijms22084085","volume":"22","author":"H Ananbeh","year":"2021","unstructured":"Ananbeh H, Vodicka P, Kupcova Skalnikova H (2021) Emerging roles of exosomes in Huntington\u2019s disease. Int J Mol Sci 22(8):4085. https:\/\/doi.org\/10.3390\/ijms22084085","journal-title":"Int J Mol Sci"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12640-019-00087-x","volume":"36","author":"SN Rai","year":"2019","unstructured":"Rai SN, Singh BK, Rathore AS, Zahra W, Keswani C, Birla H, Singh SS, Dilnashin H, Singh SP (2019) Quality control in Huntington\u2019s disease: a therapeutic target. Neurotox Res 36:612\u2013626. https:\/\/doi.org\/10.1007\/s12640-019-00087-xPMID: 31397710","journal-title":"Neurotox Res"},{"issue":"3","key":"801_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1750-3639.1997.tb00892.x","volume":"7","author":"MA Nance","year":"1997","unstructured":"Nance MA (1997) Clinical aspects of CAG repeat diseases. Brain Pathol 7(3):881\u2013900. https:\/\/doi.org\/10.1111\/j.1750-3639.1997.tb00892.x","journal-title":"Brain Pathol"},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuro.2017.01.005","volume":"61","author":"TK Chao","year":"2017","unstructured":"Chao TK, Hu J, Pringsheim T (2017) Risk factors for the onset and progression of Huntington disease. Neurotoxicology 61:79\u201399. https:\/\/doi.org\/10.1016\/j.neuro.2017.01.005","journal-title":"Neurotoxicology"},{"issue":"2","key":"801_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.10012","volume":"3","author":"JS Sunwoo","year":"2010","unstructured":"Sunwoo JS, Lee ST, Kim M (2010) A case of juvenile huntington disease in a 6-year-old boy. J Mov Disorders 3(2):45. https:\/\/doi.org\/10.14802\/jmd.10012","journal-title":"J Mov Disorders"},{"issue":"1","key":"801_CR6","doi-asserted-by":"publisher","first-page":"15729","DOI":"10.1038\/s41598-024-64105-5","volume":"14","author":"A Stanis\u0142awska-Sachadyn","year":"2024","unstructured":"Stanis\u0142awska-Sachadyn A, Krzemi\u0144ski M, Zielonka D, Krygier M, Zi\u0119tkiewicz E, S\u0142awek J, Limon J, REGISTRY investigators of the European Huntington\u2019s Disease Network (EHDN) (2024) Sex contribution to average age at onset of Huntington\u2019s disease depends on the number of (CAG) n repeats. Sci Rep 14(1):15729. https:\/\/doi.org\/10.1038\/s41598-024-64105-5","journal-title":"Sci Rep"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"117957352210925","DOI":"10.1177\/11795735221092517","volume":"14","author":"MW Ferguson","year":"2022","unstructured":"Ferguson MW, Kennedy CJ, Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A (2022) Current and possible future therapeutic options for Huntington\u2019s disease. J Cent Nerv Syst Disease 14:11795735221092517. https:\/\/doi.org\/10.1177\/11795735221092517","journal-title":"J Cent Nerv Syst Disease"},{"issue":"2","key":"801_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/ijms23020780","volume":"23","author":"S Maity","year":"2022","unstructured":"Maity S, Komal P, Kumar V, Saxena A, Tungekar A, Chandrasekar V (2022) Impact of ER stress and ER-mitochondrial crosstalk in Huntington\u2019s disease. Int J Mol Sci 23(2):780. https:\/\/doi.org\/10.3390\/ijms23020780","journal-title":"Int J Mol Sci"},{"issue":"1","key":"801_CR9","doi-asserted-by":"publisher","first-page":"256404","DOI":"10.1155\/2013\/256404","volume":"2013","author":"CM Pereira","year":"2013","unstructured":"Pereira CM (2013) Crosstalk between endoplasmic reticulum stress and protein misfolding in neurodegenerative diseases. Int Sch Res Notices 2013(1):256404. https:\/\/doi.org\/10.1155\/2013\/256404","journal-title":"Int Sch Res Notices"},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Chakole RD, Nemade LS, Kale NK, Borah S, Deokar SS, Behera A (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion 71:83\u201392. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","journal-title":"Mitochondrion"},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"104961","DOI":"10.1016\/j.neubiorev.2022.104961","volume":"144","author":"MU Rehman","year":"2023","unstructured":"Rehman MU, Sehar N, Dar NJ, Khan A, Arafah A, Rashid S, Rashid SM, Ganaie MA (2023) Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments. Neurosci Biobehavioral Reviews 144:104961. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104961","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00702-014-1188-0","volume":"121","author":"IR Stojanovic","year":"2014","unstructured":"Stojanovic IR, Kostic M, Ljubisavljevic S (2014) The role of glutamate and its receptors in multiple sclerosis. J Neural Transm 121:945\u2013955. https:\/\/doi.org\/10.1007\/s00702-014-1188-0","journal-title":"J Neural Transm"},{"issue":"1","key":"801_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Translational Neurodegeneration 11(1):3. https:\/\/doi.org\/10.1186\/s40035-021-00278-7","journal-title":"Translational Neurodegeneration"},{"issue":"7","key":"801_CR14","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.3390\/ijms13078722","volume":"13","author":"TK Lin","year":"2012","unstructured":"Lin TK, Cheng CH, Chen SD, Liou CW, Huang CR, Chuang YC (2012) Mitochondrial dysfunction and oxidative stress promote apoptotic cell death in the striatum via cytochrome c\/caspase-3 signaling cascade following chronic rotenone intoxication in rats. Int J Mol Sci 13(7):8722\u20138739. https:\/\/doi.org\/10.3390\/ijms13078722","journal-title":"Int J Mol Sci"},{"issue":"3","key":"801_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10(3):210\u2013215. https:\/\/doi.org\/10.1038\/nri2725","journal-title":"Nat Rev Immunol"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10787-020-00787-3","volume":"29","author":"P Saroj","year":"2021","unstructured":"Saroj P, Bansal Y, Singh R, Akhtar A, Sodhi RK, Bishnoi M, Sah SP, Kuhad A (2021) Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington\u2019s disease through inhibition of NF-\u03baB mediated neuroinflammatory markers and activation of cAMP\/CREB\/BDNF signaling pathway. Inflammopharmacology 29:499\u2013511. https:\/\/doi.org\/10.1007\/s10787-020-00787-3","journal-title":"Inflammopharmacology"},{"issue":"12","key":"801_CR17","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch ET, Raymond LA (2019) Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J Neurosci Res 97(12):1636\u20131654. https:\/\/doi.org\/10.1002\/jnr.24495","journal-title":"J Neurosci Res"},{"issue":"15","key":"801_CR18","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.3390\/ijms22157820","volume":"22","author":"B Tarnacka","year":"2021","unstructured":"Tarnacka B, Jopowicz A, Ma\u015bli\u0144ska M (2021) Copper, iron, and manganese toxicity in neuropsychiatric conditions. Int J Mol Sci 22(15):7820. https:\/\/doi.org\/10.3390\/ijms22157820","journal-title":"Int J Mol Sci"},{"key":"801_CR19","doi-asserted-by":"publisher","unstructured":"Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M (2024) Heavy Metal Interactions with Neuroglia and Gut Microbiota: implications for Huntington\u2019s Disease. Cells 13(13). https:\/\/doi.org\/10.3390\/cells13131144","DOI":"10.3390\/cells13131144"},{"issue":"12","key":"801_CR20","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/biomedicines11123331","volume":"11","author":"G Nittari","year":"2023","unstructured":"Nittari G, Roy P, Martinelli I, Bellitto V, Tomassoni D, Traini E, Tayebati SK, Amenta F (2023) Rodent models of Huntington\u2019s Disease: an overview. Biomedicines 11(12):3331. https:\/\/doi.org\/10.3390\/biomedicines11123331","journal-title":"Biomedicines"},{"key":"801_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuro.2017.03.004","volume":"60","author":"GA Dominah","year":"2017","unstructured":"Dominah GA, McMinimy RA, Kallon S, Kwakye GF (2017) Acute exposure to chlorpyrifos caused NADPH oxidase mediated oxidative stress and neurotoxicity in a striatal cell model of Huntington\u2019s disease. Neurotoxicology 60:54\u201369. https:\/\/doi.org\/10.1016\/j.neuro.2017.03.004","journal-title":"Neurotoxicology"},{"key":"801_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2022.02.013","volume":"97","author":"M Wang","year":"2022","unstructured":"Wang M, Liu D, Yang S, Li Y, Lian X (2022) Smoking, alcohol consumption, and age at onset of Huntington\u2019s disease: a mendelian randomization study. Parkinsonism Relat Disord 97:34\u201338. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.02.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"801_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1708\/4205.41943","volume":"59","author":"B Papanna","year":"2024","unstructured":"Papanna B, Lazzari C, Rabottini M (2024) Huntington\u2019s disease prevalence in Asia: a systematic review and meta-analysis. Rivista Di Psichiatria 59(1):4\u201312. https:\/\/doi.org\/10.1708\/4205.41943","journal-title":"Rivista Di Psichiatria"},{"issue":"12","key":"801_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/jnnp-2020-323241","volume":"91","author":"F Squitieri","year":"2020","unstructured":"Squitieri F, Maffi S, Al Harasi S, Al Salmi Q, D\u2019Alessio B, Capelli G, Mazza T (2020) Incidence and prevalence of Huntington disease (HD) in the Sultanate of Oman: the first Middle East post-HTT service-based study. J Neurol Neurosurg Psychiatry 91(12):1359\u20131360. https:\/\/doi.org\/10.1136\/jnnp-2020-323241","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"801_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3988\/jcn.2022.0212","volume":"19","author":"CY Lee","year":"2023","unstructured":"Lee CY, Ro JS, Jung H, Kim M, Jeon B, Lee JY (2023) Increased 10-year prevalence of Huntington\u2019s disease in South Korea: an analysis of medical expenditure through the national healthcare system. J Clin Neurol (Seoul Korea) 19(2):147. https:\/\/doi.org\/10.3988\/jcn.2022.0212","journal-title":"J Clin Neurol (Seoul Korea)"},{"issue":"16supplement","key":"801_CR26","doi-asserted-by":"publisher","first-page":"P4","DOI":"10.1212\/WNL.88.16_supplement.P4.323","volume":"88","author":"Y Seliverstov","year":"2017","unstructured":"Seliverstov Y, Dranitsyna M, Ivashynka A, Kravchenko M, Klyushnikov S, Illarioshkin S (2017) Huntington Disease in Russia: an epidemiological challenge?(P4. 323). Neurology 88(16supplement):P4\u2013323. https:\/\/doi.org\/10.1212\/WNL.88.16_supplement.P4.323","journal-title":"Neurology"},{"issue":"2","key":"801_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/aian.AIAN_505_19","volume":"23","author":"Z Hussain","year":"2020","unstructured":"Hussain Z, Mukherjee A, Ganguly G, Joardar A, Roy S, Guin DS, Sinharoy U, Biswas A, Das SK (2020) Clinical profile of genetically proven Huntington\u2019s disease patients from Eastern India. Ann Indian Acad Neurol 23(2):195\u2013200. https:\/\/doi.org\/10.4103\/aian.AIAN_505_19","journal-title":"Ann Indian Acad Neurol"},{"issue":"12","key":"801_CR28","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T (2022) Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov Disord 37(12):2327\u20132335. https:\/\/doi.org\/10.1002\/mds.29228","journal-title":"Mov Disord"},{"key":"801_CR29","doi-asserted-by":"publisher","unstructured":"Tandon S, Aggarwal P, Sarkar S (2024 Mar) Polyglutamine disorders: Pathogenesis and potential drug interventions. Life Sci 14:122562. https:\/\/doi.org\/10.1016\/j.lfs.2024.122562","DOI":"10.1016\/j.lfs.2024.122562"},{"issue":"6","key":"801_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, Caruso C (2022) Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol 20(6):1116. https:\/\/doi.org\/10.2174\/1570159X19666211201094608","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"801_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discovery 16(7):472\u2013486. https:\/\/doi.org\/10.1038\/nrd.2017.16","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"801_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JHD-200445","volume":"10","author":"J Donaldson","year":"2021","unstructured":"Donaldson J, Powell S, Rickards N, Holmans P, Jones L (2021) What is the pathogenic CAG expansion length in Huntington\u2019s disease? J Huntington\u2019s Disease 10(1):175\u2013202. https:\/\/doi.org\/10.3233\/JHD-200445","journal-title":"J Huntington\u2019s Disease"},{"key":"801_CR33","doi-asserted-by":"publisher","unstructured":"Hub\u010d\u00edkov\u00e1, K., Rak\u00fas, T., M\u00fchlb\u00e4ck, A., Benetin, J., Bruncvik, L., Petr\u00e1\u0161ov\u00e1, Z.,\u2026 Brunovsk\u00fd, M. (2022). Psychosocial impact of Huntington\u2019s disease and incentives to improve care for affected families in the underserved region of the Slovak republic.Journal of Personalized Medicine, 12(12), 1941. https:\/\/doi.org\/10.3390\/jpm12121941","DOI":"10.3390\/jpm12121941"},{"issue":"10","key":"801_CR34","doi-asserted-by":"publisher","first-page":"e1009863","DOI":"10.1371\/journal.pgen.1009863","volume":"17","author":"MA Gold","year":"2021","unstructured":"Gold MA, Whalen JM, Freon K, Hong Z, Iraqui I, Lambert SA, Freudenreich CH (2021) Restarted replication forks are error-prone and cause CAG repeat expansions and contractions. PLoS Genet 17(10):e1009863. https:\/\/doi.org\/10.1371\/journal.pgen.1009863","journal-title":"PLoS Genet"},{"issue":"1","key":"801_CR35","doi-asserted-by":"publisher","first-page":"dmm031930","DOI":"10.1242\/dmm.031930","volume":"11","author":"TH Massey","year":"2018","unstructured":"Massey TH, Jones L (2018) The central role of DNA damage and repair in CAG repeat diseases. Dis Models Mech 11(1):dmm031930. https:\/\/doi.org\/10.1242\/dmm.031930","journal-title":"Dis Models Mech"},{"key":"801_CR36","doi-asserted-by":"publisher","unstructured":"Lee, J. M., Huang, Y., Orth, M., Gillis, T., Siciliano, J., Hong, E.,\u2026 Gusella, J.F. (2022). Genetic modifiers of Huntington disease differentially influence motor and cognitive domains. The American Journal of Human Genetics, 109(5), 885\u2013899. https:\/\/doi.org\/10.1016\/j.ajhg.2022.03.004Podvin, S., Reardon, H. T., Yin, K., Mosier, C., & Hook, V. (2019). Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. Journal of neurology, 266, 551\u2013564. https:\/\/doi.org\/10.1007\/s00415-018-8940-6","DOI":"10.1016\/j.ajhg.2022.03.004Podvin,"},{"key":"801_CR37","doi-asserted-by":"publisher","unstructured":"Podvin, S., Reardon, H. T., Yin, K., Mosier, C., & Hook, V. (2019). Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. Journal of neurology, 266, 551\u2013564. https:\/\/doi.org\/10.1007\/s00415-018-8940-6","DOI":"10.1007\/s00415-018-8940-6"},{"key":"801_CR38","unstructured":"Tereshchenko A (2018) Brain Structure and Function in Juvenile-Onset Huntington\u2019s Disease (Doctoral dissertation, PhD thesis, University of Iowa)"},{"key":"801_CR39","unstructured":"Palpagama TH An investigation of neuronal cell death and neuroinflammation in the middle cingulate cortex in Huntington\u2019s Disease (Doctoral dissertation, ResearchSpace@ Auckland)"},{"key":"801_CR40","unstructured":"M\u00fchlb\u00e4ck A Clinical Applicability of Cognitive Testing in Huntington Disease"},{"issue":"19","key":"801_CR41","doi-asserted-by":"publisher","first-page":"e2407","DOI":"10.1212\/WNL.0000000000011823","volume":"96","author":"JL Schultz","year":"2021","unstructured":"Schultz JL, Saft C, Nopoulos PC (2021) Association of CAG repeat length in the Huntington gene with cognitive performance in young adults. Neurology 96(19):e2407\u2013e2413. https:\/\/doi.org\/10.1212\/WNL.0000000000011823","journal-title":"Neurology"},{"issue":"6","key":"801_CR42","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biomedicines10061432","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A (2022) Molecular pathophysiological mechanisms in Huntington\u2019s disease. Biomedicines 10(6):1432. https:\/\/www.mdpi.com\/2227-9059\/10\/6\/1432#","journal-title":"Biomedicines"},{"issue":"1","key":"801_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-140134","volume":"4","author":"KE Glajch","year":"2015","unstructured":"Glajch KE, Sadri-Vakili G (2015) Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis. J Huntington\u2019s Disease 4(1):1\u20135. https:\/\/doi.org\/10.3233\/JHD-140134","journal-title":"J Huntington\u2019s Disease"},{"issue":"2","key":"801_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41418-020-00667-x","volume":"28","author":"F Le Guerrou\u00e9","year":"2021","unstructured":"Le Guerrou\u00e9 F, Youle RJ (2021) Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective. Cell Death Differ 28(2):439\u2013454. https:\/\/doi.org\/10.1038\/s41418-020-00667-x","journal-title":"Cell Death Differ"},{"issue":"7","key":"801_CR45","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau CM (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regeneration Res 18(7):1472\u20131477. https:\/\/doi.org\/10.4103\/1673-5374.360289","journal-title":"Neural Regeneration Res"},{"issue":"4","key":"801_CR46","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","volume":"483","author":"LA Raymond","year":"2017","unstructured":"Raymond LA (2017) Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochem Biophys Res Commun 483(4):1051\u20131062. https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.058","journal-title":"Biochem Biophys Res Commun"},{"key":"801_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","volume":"9","author":"HM Yang","year":"2017","unstructured":"Yang HM, Yang S, Huang SS, Tang BS, Guo JF (2017) Microglial activation in the pathogenesis of Huntington\u2019s disease. Front Aging Neurosci 9:193. https:\/\/doi.org\/10.3389\/fnagi.2017.00193","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"801_CR48","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/ijms23020780","volume":"23","author":"S Maity","year":"2022","unstructured":"Maity S, Komal P, Kumar V, Saxena A, Tungekar A, Chandrasekar V (2022) Impact of ER stress and ER-mitochondrial crosstalk in Huntington\u2019s disease. Int J Mol Sci 23(2):780. https:\/\/www.mdpi.com\/1422-0067\/23\/2\/780#","journal-title":"Int J Mol Sci"},{"key":"801_CR49","unstructured":"Mc Cluskey M. Study of vesicular glycolysis in health and Huntington\u2019s Disease (Doctoral dissertation, Universit\u00e9 Grenoble Alpes [2020-\u2026"},{"key":"801_CR50","doi-asserted-by":"publisher","first-page":"689332","DOI":"10.3389\/fncel.2021.689332","volume":"15","author":"JC Barron","year":"2021","unstructured":"Barron JC, Hurley EP, Parsons MP (2021) Huntingtin and the synapse. Front Cell Neurosci 15:689332. https:\/\/doi.org\/10.3389\/fncel.2021.689332","journal-title":"Front Cell Neurosci"},{"key":"801_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","volume":"33","author":"M Matsuda","year":"2019","unstructured":"Matsuda M, Huh Y, Ji RR (2019) Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth 33:131\u2013139. https:\/\/doi.org\/10.1007\/s00540-018-2579-4","journal-title":"J Anesth"},{"issue":"4","key":"801_CR52","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang XI, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep 13(4):3391\u20133396. https:\/\/doi.org\/10.3892\/mmr.2016.4948","journal-title":"Mol Med Rep"},{"issue":"11","key":"801_CR53","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23(11):5938. https:\/\/doi.org\/10.3390\/ijms23115938","journal-title":"Int J Mol Sci"},{"issue":"2","key":"801_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1073858413504466","volume":"20","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV (2014) Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscientist 20(2):160\u2013172. https:\/\/doi.org\/10.1177\/1073858413504466","journal-title":"Neuroscientist"},{"issue":"10","key":"801_CR55","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/molecules27103194","volume":"27","author":"A Rauf","year":"2022","unstructured":"Rauf A, Badoni H, Abu-Izneid T, Olatunde A, Rahman MM, Painuli S, Semwal P, Wilairatana P, Mubarak MS (2022) Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases. Molecules 27(10):3194. https:\/\/doi.org\/10.3390\/molecules27103194","journal-title":"Molecules"},{"key":"801_CR56","doi-asserted-by":"publisher","unstructured":"Khoury ZS, Sohail F, Wang J, Mendoza M, Raake M, Silat MT, Bathinapatta MR, Sadeghzadegan A, Meghana P, Paul J (2024) Neuroinflammation: a critical factor in neurodegenerative disorders. Cureus 16(6). https:\/\/doi.org\/10.7759\/cureus.62310","DOI":"10.7759\/cureus.62310"},{"issue":"1","key":"801_CR57","doi-asserted-by":"publisher","first-page":"480739","DOI":"10.1155\/2013\/480739","volume":"2013","author":"G Ramesh","year":"2013","unstructured":"Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediat Inflamm 2013(1):480739. https:\/\/doi.org\/10.1155\/2013\/480739","journal-title":"Mediat Inflamm"},{"issue":"1","key":"801_CR58","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s42003-022-04120-2","volume":"5","author":"R Brinkschulte","year":"2022","unstructured":"Brinkschulte R, Fu\u00dfh\u00f6ller DM, Hoss F, Rodr\u00edguez-Alc\u00e1zar JF, Lauterbach MA, Kolbe CC, Rauen M, Ince S, Herrmann C, Latz E, Geyer M (2022) ATP-binding and hydrolysis of human NLRP3. Commun Biology 5(1):1176. https:\/\/doi.org\/10.1038\/s42003-022-04120-2","journal-title":"Commun Biology"},{"key":"801_CR59","doi-asserted-by":"publisher","first-page":"1360066","DOI":"10.3389\/fncel.2024.1360066","volume":"18","author":"E Paldino","year":"2024","unstructured":"Paldino E, Migliorato G, Fusco FR (2024) Neuroimmune pathways involvement in neurodegeneration of R6\/2 mouse model of Huntington\u2019s disease. Front Cell Neurosci 18:1360066. https:\/\/doi.org\/10.3389\/fncel.2024.1360066","journal-title":"Front Cell Neurosci"},{"key":"801_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang KH, Wu YR, Chen YC, Chen CM (2015) Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun 44:121\u2013127. https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011","journal-title":"Brain Behav Immun"},{"issue":"4","key":"801_CR61","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/17460441.2021.1844179","volume":"16","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zahid A, Ismail H, Tang Y, Jin T, Tao J (2021) An overview of disease models for NLRP3 inflammasome over-activation. Expert Opin Drug Discov 16(4):429\u2013446. https:\/\/doi.org\/10.1080\/17460441.2021.1844179","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"801_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR (2016) Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly. J Huntington\u2019s Disease 5(3):217\u2013237. https:\/\/doi.org\/10.3233\/JHD-160205","journal-title":"J Huntington\u2019s Disease"},{"issue":"6","key":"801_CR63","doi-asserted-by":"publisher","first-page":"e10248","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11(6):e10248. https:\/\/doi.org\/10.15252\/emmm.201810248","journal-title":"EMBO Mol Med"},{"key":"801_CR64","doi-asserted-by":"publisher","unstructured":"Muhammad M (2019) Tumor necrosis factor alpha: a major cytokine of brain neuroinflammation. Cytokines 861231. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.10.001","DOI":"10.1016\/j.pharmthera.2007.10.001"},{"key":"801_CR65","doi-asserted-by":"publisher","first-page":"155066","DOI":"10.1016\/j.cyto.2020.155066","volume":"130","author":"PM Sharif","year":"2020","unstructured":"Sharif PM, Jabbari P, Razi S, Keshavarz-Fathi M, Rezaei N (2020) Importance of TNF-alpha and its alterations in the development of cancers. Cytokine 130:155066. https:\/\/doi.org\/10.1016\/j.cyto.2020.155066","journal-title":"Cytokine"},{"issue":"5","key":"801_CR66","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","volume":"90","author":"M Pickering","year":"2005","unstructured":"Pickering M, Cumiskey D, O\u2019Connor JJ (2005) Actions of TNF-\u03b1 on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90(5):663\u2013670. https:\/\/doi.org\/10.1113\/expphysiol.2005.030734","journal-title":"Exp Physiol"},{"issue":"1","key":"801_CR67","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J (2014) Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014(1):861231. https:\/\/doi.org\/10.1155\/2014\/861231","journal-title":"Mediat Inflamm"},{"issue":"4","key":"801_CR68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3934\/Neuroscience.2021031","volume":"8","author":"EM Abd-El-Basset","year":"2021","unstructured":"Abd-El-Basset EM, Rao MS, Alshawaf SM, Ashkanani HK, Kabli AH (2021) Tumor necrosis factor (TNF) induces astrogliosis, microgliosis and promotes survival of cortical neurons. AIMS Neurosci 8(4):558. https:\/\/doi.org\/10.3934\/Neuroscience.2021031","journal-title":"AIMS Neurosci"},{"issue":"8","key":"801_CR69","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/cells11081251","volume":"11","author":"FA de Freitas","year":"2022","unstructured":"de Freitas FA, Levy D, Reichert CO, Cunha-Neto E, Kalil J, Bydlowski SP (2022) Effects of oxysterols on immune cells and related diseases. Cells 11(8):1251. https:\/\/doi.org\/10.3390\/cells11081251","journal-title":"Cells"},{"issue":"8","key":"801_CR70","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nri1664","volume":"5","author":"SM Allan","year":"2005","unstructured":"Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5(8):629\u2013640. https:\/\/doi.org\/10.1038\/nri1664","journal-title":"Nat Rev Immunol"},{"key":"801_CR71","doi-asserted-by":"publisher","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 2021 Dec 1:1\u20133. https:\/\/doi.org\/10.1007\/s10787-021-00889-6","DOI":"10.1007\/s10787-021-00889-6"},{"key":"801_CR72","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fncel.2018.00336","volume":"12","author":"TJ Craddock","year":"2018","unstructured":"Craddock TJ, Michalovicz LT, Kelly KA, Rice MA Jr, Miller DB, Klimas NG, Morris M, O\u2019Callaghan JP, Broderick G (2018) A logic model of neuronal-glial interaction suggests altered homeostatic regulation in the perpetuation of neuroinflammation. Front Cell Neurosci 12:336. https:\/\/doi.org\/10.3389\/fncel.2018.00336","journal-title":"Front Cell Neurosci"},{"key":"801_CR73","doi-asserted-by":"publisher","first-page":"155582","DOI":"10.1016\/j.cyto.2021.155582","volume":"144","author":"KK Kummer","year":"2021","unstructured":"Kummer KK, Zeidler M, Kalpachidou T, Kress M (2021) Role of IL-6 in the regulation of neuronal development, survival and function. Cytokine 144:155582. https:\/\/doi.org\/10.1016\/j.cyto.2021.155582","journal-title":"Cytokine"},{"key":"801_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijdevneu.2018.11.003","volume":"77","author":"D Guidolin","year":"2019","unstructured":"Guidolin D, Fede C, Tortorella C (2019) Nerve cells developmental processes and the dynamic role of cytokine signaling. Int J Dev Neurosci 77:3\u201317. https:\/\/doi.org\/10.1016\/j.ijdevneu.2018.11.003","journal-title":"Int J Dev Neurosci"},{"key":"801_CR75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biopha.2016.11.125","volume":"85","author":"S Kumar","year":"2017","unstructured":"Kumar S, Singh RK, Bhardwaj TR (2017) Therapeutic role of nitric oxide as emerging molecule. Biomed Pharmacother 85:182\u2013201. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.125","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"801_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Vanhoutte PM, Leung SW (2015) Vascular nitric oxide: beyond eNOS. J Pharmacol Sci 129(2):83\u201394. https:\/\/doi.org\/10.1016\/j.jphs.2015.09.002","journal-title":"J Pharmacol Sci"},{"key":"801_CR77","doi-asserted-by":"crossref","unstructured":"Danylovych GV, Bohach TV, Danylovych YV The biosynthesis of nitric oxide from L-arginine. Nitric oxide formation features and its functional role in mitochondria. Ukrainian Biochem J. 2018(90,\u2116 1):3\u201324","DOI":"10.15407\/ubj90.01.003"},{"issue":"3\u20134","key":"801_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ceca.2004.02.011","volume":"36","author":"MA Moro","year":"2004","unstructured":"Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I (2004) Role of nitric oxide after brain ischaemia. Cell Calcium 36(3\u20134):265\u2013275. https:\/\/doi.org\/10.1016\/j.ceca.2004.02.011","journal-title":"Cell Calcium"},{"key":"801_CR79","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A (2019) The role of microglia and astrocytes in Huntington\u2019s disease. Front Mol Neurosci 12:258. https:\/\/doi.org\/10.3389\/fnmol.2019.00258","journal-title":"Front Mol Neurosci"},{"key":"801_CR80","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fncel.2015.00322","volume":"9","author":"JE Yuste","year":"2015","unstructured":"Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F (2015) Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci 9:322. https:\/\/doi.org\/10.3389\/fncel.2015.00322","journal-title":"Front Cell Neurosci"},{"key":"801_CR81","doi-asserted-by":"publisher","unstructured":"Rao P, Knaus EE (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. Journal of pharmacy & pharmaceutical sciences.;11(2):81s-110s. https:\/\/doi.org\/10.18433\/J3T886","DOI":"10.18433\/J3T886"},{"issue":"42","key":"801_CR82","doi-asserted-by":"publisher","first-page":"14850","DOI":"10.1523\/JNEUROSCI.3922-11.2011","volume":"31","author":"GE Serrano","year":"2011","unstructured":"Serrano GE, Lelutiu N, Rojas A, Cochi S, Shaw R, Makinson CD, Wang D, FitzGerald GA, Dingledine R (2011) Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J Neurosci 31(42):14850\u201314860. https:\/\/doi.org\/10.1523\/JNEUROSCI.3922-11.2011","journal-title":"J Neurosci"},{"issue":"4","key":"801_CR83","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tips.2009.01.002","volume":"30","author":"SH Choi","year":"2009","unstructured":"Choi SH, Aid S, Bosetti F (2009) The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30(4):174\u2013181. https:\/\/doi.org\/10.1016\/j.tips.2009.01.002","journal-title":"Trends Pharmacol Sci"},{"issue":"21\u201322","key":"801_CR84","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.ccr.2009.05.011","volume":"253","author":"H Kozlowski","year":"2009","unstructured":"Kozlowski H, Janicka-Klos A, Brasun J, Gaggelli E, Valensin D, Valensin G (2009) Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation). Coord Chem Rev 253(21\u201322):2665\u20132685. https:\/\/doi.org\/10.1016\/j.ccr.2009.05.011","journal-title":"Coord Chem Rev"},{"key":"801_CR85","doi-asserted-by":"publisher","first-page":"128350","DOI":"10.1016\/j.chemosphere.2020.128350","volume":"262","author":"JG Paithankar","year":"2021","unstructured":"Paithankar JG, Saini S, Dwivedi S, Sharma A, Chowdhuri DK (2021) Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction. Chemosphere 262:128350. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.128350","journal-title":"Chemosphere"},{"issue":"18","key":"801_CR86","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1089\/ars.2017.7272","volume":"28","author":"C Garza-Lomb\u00f3","year":"2018","unstructured":"Garza-Lomb\u00f3 C, Posadas Y, Quintanar L, Gonsebatt ME, Franco R (2018) Neurotoxicity linked to dysfunctional metal ion homeostasis and xenobiotic metal exposure: redox signaling and oxidative stress. Antioxid Redox Signal 28(18):1669\u20131703. https:\/\/doi.org\/10.1089\/ars.2017.7272","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"801_CR87","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/toxsci\/kfq174","volume":"117","author":"BB Williams","year":"2010","unstructured":"Williams BB, Kwakye GF, Wegrzynowicz M, Li D, Aschner M, Erikson KM, Bowman AB (2010) Altered manganese homeostasis and manganese toxicity in a Huntington\u2019s disease striatal cell model are not explained by defects in the iron transport system. Toxicol Sci 117(1):169\u2013179. https:\/\/doi.org\/10.1093\/toxsci\/kfq174","journal-title":"Toxicol Sci"},{"key":"801_CR88","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuro.2017.07.026","volume":"64","author":"MR Bryan","year":"2018","unstructured":"Bryan MR, Uhouse MA, Nordham KD, Joshi P, Rose DI, O\u2019Brien MT, Aschner M, Bowman AB (2018) Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line. Neurotoxicology 64:185\u2013194. https:\/\/doi.org\/10.1016\/j.neuro.2017.07.026","journal-title":"Neurotoxicology"},{"issue":"3","key":"801_CR89","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR (2014) Iron dysregulation in Huntington\u2019s disease. J Neurochem 130(3):328\u2013350. https:\/\/doi.org\/10.1111\/jnc.12739","journal-title":"J Neurochem"},{"issue":"13","key":"801_CR90","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/cells13131144","volume":"13","author":"Y Tizabi","year":"2024","unstructured":"Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M (2024) Heavy Metal Interactions with Neuroglia and Gut Microbiota: implications for Huntington\u2019s Disease. Cells 13(13):1144. https:\/\/www.mdpi.com\/2073-4409\/13\/13\/1144#","journal-title":"Cells"},{"key":"801_CR91","doi-asserted-by":"publisher","first-page":"125836","DOI":"10.1016\/j.chemosphere.2020.125836","volume":"247","author":"TD Fernando","year":"2020","unstructured":"Fernando TD, Jayawardena BM, Arachchige YL (2020) Variation of different metabolites and heavy metals in Oryza sativa L., related to chronic kidney disease of unknown etiology in Sri Lanka. Chemosphere 247:125836. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.125836","journal-title":"Chemosphere"},{"issue":"6","key":"801_CR92","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/antiox9060492","volume":"9","author":"JJ Branca","year":"2020","unstructured":"Branca JJ, Fiorillo C, Carrino D, Paternostro F, Taddei N, Gulisano M, Pacini A, Becatti M (2020) Cadmium-induced oxidative stress: focus on the central nervous system. Antioxidants 9(6):492. https:\/\/doi.org\/10.3390\/antiox9060492","journal-title":"Antioxidants"},{"key":"801_CR93","doi-asserted-by":"publisher","unstructured":"Dhilleswara Rao H, Chintada V, Veeraiah K, Cadmium, and Its Neurotoxic Effects. InCadmium Toxicity in Water: ChallengesSolutions 2024 Apr 9 (pp. 61\u201372). Cham: Springer Nature Switzerland. https:\/\/doi.org\/10.1007\/978-3-031-54005-9_4","DOI":"10.1007\/978-3-031-54005-9_4"},{"issue":"1","key":"801_CR94","doi-asserted-by":"publisher","first-page":"729430","DOI":"10.1100\/2012\/729430","volume":"2012","author":"MW Ashraf","year":"2012","unstructured":"Ashraf MW (2012) Levels of heavy metals in popular cigarette brands and exposure to these metals via smoking. Sci World J 2012(1):729430. https:\/\/doi.org\/10.1100\/2012\/729430","journal-title":"Sci World J"},{"key":"801_CR95","doi-asserted-by":"publisher","unstructured":"Gupta RK, Gupta RC Placental toxicity. InReproductive and developmental toxicology 2022 Jan 1 (pp. 1373\u20131397). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-323-89773-0.00068-0","DOI":"10.1016\/B978-0-323-89773-0.00068-0"},{"key":"801_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2015.00124","volume":"9","author":"M Chin-Chan","year":"2015","unstructured":"Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B (2015) Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9:124. https:\/\/doi.org\/10.3389\/fncel.2015.00124","journal-title":"Front Cell Neurosci"},{"key":"801_CR97","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cortex.2015.10.003","volume":"74","author":"F S\u00e1nchez-Santed","year":"2016","unstructured":"S\u00e1nchez-Santed F, Colomina MT, Hern\u00e1ndez EH (2016) Organophosphate pesticide exposure and neurodegeneration. Cortex 74:417\u2013426. https:\/\/doi.org\/10.1016\/j.cortex.2015.10.003","journal-title":"Cortex"},{"key":"801_CR98","doi-asserted-by":"publisher","unstructured":"Filipov NM Pesticides exposures and parkinsonism: experimental and Epidemiological Evidence of Association. InParkinsonism and the Environment 2022 Feb 18 (pp. 131\u2013154). Cham: Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-87451-3_6","DOI":"10.1007\/978-3-030-87451-3_6"},{"issue":"21","key":"801_CR99","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.3390\/ijms232113043","volume":"23","author":"LP Dolgacheva","year":"2022","unstructured":"Dolgacheva LP, Zinchenko VP, Goncharov NV (2022) Molecular and cellular interactions in pathogenesis of sporadic Parkinson disease. Int J Mol Sci 23(21):13043. https:\/\/doi.org\/10.3390\/ijms232113043","journal-title":"Int J Mol Sci"},{"issue":"5","key":"801_CR100","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s12640-022-00552-0","volume":"40","author":"M Sarailoo","year":"2022","unstructured":"Sarailoo M, Afshari S, Asghariazar V, Safarzadeh E, Dadkhah M (2022) Cognitive impairment and neurodegenerative diseases development associated with organophosphate pesticides exposure: a review study. Neurotox Res 40(5):1624\u20131643. https:\/\/doi.org\/10.1007\/s12640-022-00552-0","journal-title":"Neurotox Res"},{"issue":"2\u20133","key":"801_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pestbp.2009.04.001","volume":"94","author":"A Mehta","year":"2009","unstructured":"Mehta A, Verma RS, Srivastava N (2009) Chlorpyrifos induced alterations in the levels of hydrogen peroxide, nitrate and nitrite in rat brain and liver. Pestic Biochem Physiol 94(2\u20133):55\u201359. https:\/\/doi.org\/10.1016\/j.pestbp.2009.04.001","journal-title":"Pestic Biochem Physiol"},{"key":"801_CR102","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nbd.2018.05.019","volume":"117","author":"N Singh","year":"2018","unstructured":"Singh N, Lawana V, Luo J, Phong P, Abdalla A, Palanisamy B, Rokad D, Sarkar S, Jin H, Anantharam V, Kanthasamy AG (2018) Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: implications for mitochondria mediated oxidative stress signaling events. Neurobiol Dis 117:82\u2013113. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.019","journal-title":"Neurobiol Dis"},{"key":"801_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tox.2016.01.001","volume":"340","author":"YS Lee","year":"2016","unstructured":"Lee YS, Lewis JA, Ippolito DL, Hussainzada N, Lein PJ, Jackson DA, Stallings JD (2016) Repeated exposure to neurotoxic levels of chlorpyrifos alters hippocampal expression of neurotrophins and neuropeptides. Toxicology 340:53\u201362. https:\/\/doi.org\/10.1016\/j.tox.2016.01.001","journal-title":"Toxicology"},{"issue":"4","key":"801_CR104","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ntt.2010.03.008","volume":"32","author":"ML Middlemore-Risher","year":"2010","unstructured":"Middlemore-Risher ML, Buccafusco JJ, Terry AV Jr (2010) Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats. Neurotoxicol Teratol 32(4):415\u2013424. https:\/\/doi.org\/10.1016\/j.ntt.2010.03.008","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"801_CR105","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0091-3057(92)90523-I","volume":"42","author":"CN Pope","year":"1992","unstructured":"Pope CN, Chakraborti TK, Chapman ML, Farrar JD (1992) Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol Biochem Behav 42(2):251\u2013256. https:\/\/doi.org\/10.1016\/0091-3057(92)90523-I","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"801_CR106","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s10787-023-01259-0","volume":"31","author":"MR Alam","year":"2023","unstructured":"Alam MR, Singh S (2023) Neuromodulation in Parkinson\u2019s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach. Inflammopharmacology 31(4):1605\u20131627. https:\/\/doi.org\/10.1007\/s10787-023-01259-0","journal-title":"Inflammopharmacology"},{"issue":"1","key":"801_CR107","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1038\/cddis.2012.194","volume":"4","author":"A Vaarmann","year":"2013","unstructured":"Vaarmann A, Kovac S, Holmstr\u00f6m KM, Gandhi S, Abramov AY (2013) Dopamine protects neurons against glutamate-induced excitotoxicity. Cell Death Dis 4(1):e455. https:\/\/doi.org\/10.1038\/cddis.2012.194","journal-title":"Cell Death Dis"},{"issue":"s3","key":"801_CR108","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42(s3):S125\u2013S152. https:\/\/doi.org\/10.3233\/JAD-132738","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"801_CR109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/antiox6030051","volume":"6","author":"F Ahmadinejad","year":"2017","unstructured":"Ahmadinejad F, Geir M\u00f8ller S, Hashemzadeh-Chaleshtori M, Bidkhori G, Jami MS (2017) Molecular mechanisms behind free radical scavengers function against oxidative stress. Antioxidants 6(3):51. https:\/\/doi.org\/10.3390\/antiox6030051","journal-title":"Antioxidants"},{"issue":"16","key":"801_CR110","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms22168363","volume":"22","author":"A Kim","year":"2021","unstructured":"Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo PS, Rosenstock TR, Gil-Mohapel J (2021) New avenues for the treatment of Huntington\u2019s disease. Int J Mol Sci 22(16):8363. https:\/\/doi.org\/10.3390\/ijms22168363","journal-title":"Int J Mol Sci"},{"key":"801_CR111","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2021.07.003","volume":"173","author":"PR Angelova","year":"2021","unstructured":"Angelova PR (2021) Sources and triggers of oxidative damage in neurodegeneration. Free Radic Biol Med 173:52\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.07.003","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"801_CR112","doi-asserted-by":"publisher","first-page":"16","DOI":"10.56808\/3027-7922.2468","volume":"45","author":"S Deepa","year":"2021","unstructured":"Deepa S, Rymbai E, Praveen TK, Saravanan J (2021) Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington\u2019s disease. Thai J Pharm Sci 45(1):16\u201323. https:\/\/doi.org\/10.56808\/3027-7922.2468","journal-title":"Thai J Pharm Sci"},{"key":"801_CR113","doi-asserted-by":"publisher","unstructured":"Rana N, Singh C, Singh A (2023 Nov) Modeling Huntington\u2019s disease: an insight on in-vitro and in-vivo models. Behav Brain Res 11:114757. https:\/\/doi.org\/10.1016\/j.bbr.2023.114757","DOI":"10.1016\/j.bbr.2023.114757"},{"key":"801_CR114","unstructured":"Trezzi I, INVESTIGATING GLUTAMATE TOXICITY ASSOCIATED TO PARK2 MUTATIONS IN PRE-CLINICAL MODELS OF PARKINSON\u00bf S DISEASE"},{"key":"801_CR115","doi-asserted-by":"publisher","first-page":"100874","DOI":"10.1016\/j.cofs.2022.100874","volume":"47","author":"AF Furian","year":"2022","unstructured":"Furian AF, Fighera MR, Royes LF, Oliveira MS (2022) Recent advances in assessing the effects of mycotoxins using animal models. Curr Opin Food Sci 47:100874. https:\/\/doi.org\/10.1016\/j.cofs.2022.100874","journal-title":"Curr Opin Food Sci"},{"key":"801_CR116","doi-asserted-by":"publisher","first-page":"1189957","DOI":"10.3389\/fphar.2023.1189957","volume":"14","author":"PT Lum","year":"2023","unstructured":"Lum PT, Sekar M, Seow LJ, Shaikh MF, Arulsamy A, Retinasamy T, Gan SH, Gnanaraj C, Esa NM, Ramachawolran G, Subramaniyan V (2023) Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms. Front Pharmacol 14:1189957. https:\/\/doi.org\/10.3389\/fphar.2023.1189957","journal-title":"Front Pharmacol"},{"key":"801_CR117","doi-asserted-by":"publisher","unstructured":"Kumar V, Singh C, Singh A (2024) Hydroalcoholic extract of Centella asiatica ameliorate on 3-nitropropionic acid induced Huntington\u2019s like symptoms in adult zebrafish. Authorea Preprints. Jan 31. https:\/\/doi.org\/10.1089\/rej.2022.0036","DOI":"10.1089\/rej.2022.0036"},{"issue":"3","key":"801_CR118","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12035-023-03604-4","volume":"61","author":"MR Islam","year":"2024","unstructured":"Islam MR, Jony MH, Thufa GK, Akash S, Dhar PS, Rahman MM, Afroz T, Ahmed M, Hemeg HA, Rauf A, Thiruvengadam M (2024) A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington\u2019s disease. Mol Neurobiol 61(3):1237\u20131270. https:\/\/doi.org\/10.1007\/s12035-023-03604-4","journal-title":"Mol Neurobiol"},{"issue":"6","key":"801_CR119","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Yedke NG, Rahi V, Singh S, Kumar S, Arora A, Chandolia P, Kaur P, Kumar M, Koshal P, Jamwal S (2023) An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington\u2019s disease model and its relevance to drug discovery and development. Neurochem Res 48(6):1631\u20131647. https:\/\/doi.org\/10.1093\/ilar.48.4.356","journal-title":"Neurochem Res"},{"key":"801_CR120","doi-asserted-by":"crossref","unstructured":"Rai SN, Singh P, Steinbusch HW, Vamanu E, Ashraf G, Singh MP (2021) The role of vitamins in neurodegenerative disease: an update. Biomedicines 9(10):1284. https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1284# PMID: 34680401","DOI":"10.3390\/biomedicines9101284"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00801-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:04:30Z","timestamp":1769400270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00801-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00801-2","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}